ZEBETA Side Effects

6137680-9 | Abdominal Pain Upper, Barrett's Oesophagus, Depression, Insomnia, Suicidal Ideation
on Mar 16, 2009 Female patient from UNITED STATES , 72 years of age, was diagnosed with blood pressure decreased and was treated with Zebeta (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, barrett's oesophagus, depression (What is depression?), insomnia, suicidal ideation. Zebeta dosage: . During the same period patient was treated with EXFORGE (View Exforge Review and Exforge Label ).

5600389-1 | Blood Pressure Inadequately Controlled, Blood Pressure Increased, Dyspnoea, Heart Valve Incompetence, Joint Arthroplasty, Mitral Valve Calcification, Mitral Valve Incompetence, Pulmonary Congestion, Spinal Fracture
Patient was taking Zebeta (View Usage). Patient had the following side effects: blood pressure inadequately controlled, blood pressure increased, dyspnoea, heart valve incompetence, joint arthroplasty, mitral valve calcification, mitral valve incompetence, pulmonary congestion, spinal fracture on Jan 09, 2008 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with hypertension and. Zebeta dosage: 1 Tablet, Qd, Oral; 0.5 Tablet, Qd, Oral; 1 Tablet, Qd, Oral; 2.5 Mg, Qd, Oral. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ALAVERT (View Alavert Review and Alavert Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), COMBIVENT (View Combivent Review and Combivent Label ), COSOPT (TIMOLOL MALEATE, DORXOLAMIDE HYDROCHLORIDE) (View Cosopt (timolol Maleate, Dorxolamide Hydrochloride) Review and Cosopt (timolol Maleate, Dorxolamide Hydrochloride) Label ).

5575511-6 | Blood Pressure Inadequately Controlled, Blood Pressure Increased, Fatigue, Heart Valve Incompetence, Joint Arthroplasty, Mitral Valve Calcification, Spinal Fracture
Adverse event was reported on Dec 07, 2007 by a Female patient taking Zebeta (View Usage) (Dosage: 1 Tablet, Qd, Oral; 0.5 Tablet, Qd,oral; 1 Tablet, Qd, Oral) was diagnosed with hypertension and. Location: UNITED STATES , 80 years of age, After Zebeta was administered, patient had the following side effects: blood pressure inadequately controlled, blood pressure increased, fatigue, heart valve incompetence, joint arthroplasty, mitral valve calcification, spinal fracture. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ALAVERT (View Alavert Review and Alavert Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), COMBIVENT (IPTRATROPIUM BROMIDE, SALBUTAMOL SULFAT (View Combivent (iptratropium Bromide, Salbutamol Sulfat Review and Combivent (iptratropium Bromide, Salbutamol Sulfat Label ), COSOPT (View Cosopt Review and Cosopt Label ).

5535133-X | Aldolase Increased, Aspartate Aminotransferase Increased, Asthenia, Blood Creatine Phosphokinase Increased, C-reactive Protein Increased, Dysphagia, Dysstasia, Haematocrit Decreased, Haemoglobin Decreased
on Nov 07, 2007 Male patient from FRANCE , 56 years of age, was treated with Zebeta (View Usage). Patient experienced the following unwanted or unexpected effects: aldolase increased, aspartate aminotransferase increased, asthenia, blood creatine phosphokinase increased, c-reactive protein increased, dysphagia, dysstasia, haematocrit decreased, haemoglobin decreased. Zebeta dosage: 2,5 Mg (2,5 Mg, 1 In 1 D) Oral. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.


5455004-7 | Pyrexia
on Sep 11, 2007 Female patient from UNITED KINGDOM , 79 years of age, was diagnosed with cardiovascular event prophylaxis and was treated with Zebeta (View Usage). Patient had the following side effects: pyrexia. Zebeta dosage: Oral. During the same period patient was treated with STATIN (View Statin Review and Statin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5264407-5 | Arthritis, Arthropod Bite, Bronchitis, Bronchospasm, Cholelithiasis, Condition Aggravated, Deep Vein Thrombosis, Dizziness, Feeling Abnormal
Patient was taking Zebeta (View Usage). After Zebeta was administered, patient had the following side effects: arthritis (What is arthritis?), arthropod bite, bronchitis (What is bronchitis?), bronchospasm, cholelithiasis, condition aggravated, deep vein thrombosis (What is deep vein thrombosis?), dizziness (What is dizziness?), feeling abnormal on Feb 28, 2007 from UNITED STATES Additional patient health information: Female patient , 35 years of age, was diagnosed with stress (What is stress?), hypertension and. Zebeta dosage: . During the same period patient was treated with ADVAIR(FLUTICASONE PROPIONATE, SALMETEROL XINAOFATE) (Inhalant) (View Advair(fluticasone Propionate, Salmeterol Xinaofate) Review and Advair(fluticasone Propionate, Salmeterol Xinaofate) Label ), ALLEGRA D(PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE) (View Allegra-d(pseudoephedrine Hydrochloride, Fexofenadine) Review and Allegra-d(pseudoephedrine Hydrochloride, Fexofenadine) Label ), ALPRAZOLAM (3 Mg, Qd) (View Alprazolam Review and Alprazolam Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), AMOXICILLIN W/CLAVULANATE POTASSIUM(AMOXICILLIN, CLAVULANATE POTASSIUM (170 Mg, Qd) (View Amoxicillin W/clavulanate Potassium(amoxicillin, Clavulanate Potassium Review and Amoxicillin W/clavulanate Potassium(amoxicillin, Clavulanate Potassium Label ), ARTHROTEC (150 Mg, Qd) (View Arthrotec Review and Arthrotec Label ), ATENOLOL (50 Mg, Qd) (View Atenolol Review and Atenolol Label ), AVELOX (View Avelox Review and Avelox Label ). Patient was hospitalized and became disabled.

5264407-5 | Arthritis, Arthropod Bite, Bronchitis, Bronchospasm, Cholelithiasis, Condition Aggravated, Deep Vein Thrombosis, Dizziness, Feeling Abnormal
Adverse event was reported on Feb 28, 2007 by a Female patient taking Zebeta (View Usage) (Dosage: ) was diagnosed with stress (What is stress?), hypertension and. Location: UNITED STATES , 35 years of age, Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), arthropod bite, bronchitis (What is bronchitis?), bronchospasm, cholelithiasis, condition aggravated, deep vein thrombosis (What is deep vein thrombosis?), dizziness (What is dizziness?), feeling abnormal. During the same period patient was treated with ADVAIR HFA (Inhalant) (View Advair Hfa Review and Advair Hfa Label ), ALLEGRA D 12 HOUR (View Allegra-d 12 Hour Review and Allegra-d 12 Hour Label ), ALPRAZOLAM (3 Mg, Qd) (View Alprazolam Review and Alprazolam Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), AMOXICILLIN + CLAVULANATE POTASSIUM (170 Mg, Qd) (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ), ARTHROTEC (150 Mg, Qd) (View Arthrotec Review and Arthrotec Label ), ATENOLOL (50 Mg, Qd) (View Atenolol Review and Atenolol Label ), AVELOX (View Avelox Review and Avelox Label ). Patient was hospitalized and became disabled.

5234240-9 | Blood Pressure Inadequately Controlled, Blood Pressure Increased, Cardiac Valve Disease, Fatigue, Mitral Valve Calcification
on Jan 23, 2007 Female patient from UNITED STATES , 80 years of age, was diagnosed with hypertension and was treated with Zebeta (View Usage). Patient had the following side effects: blood pressure inadequately controlled, blood pressure increased, cardiac valve disease, fatigue, mitral valve calcification. Zebeta dosage: See Image. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ALAVERT (View Alavert Review and Alavert Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), COMBIVENT (View Combivent Review and Combivent Label ), COSOPT (View Cosopt Review and Cosopt Label ).

4937151-9 | Blood Pressure Increased
on Mar 07, 2006 Female patient from UNITED STATES , weighting 149.0 lb, was diagnosed with hypertension and was treated with Zebeta (View Usage). After Zebeta was administered, patient had the following side effects: blood pressure increased. Zebeta dosage: 5 Mg Qd.

4865387-4 | Atrial Fibrillation, Cardiac Arrest, Cardiac Disorder, Cardiomegaly, Coronary Artery Stenosis, Depressed Level Of Consciousness, Post Procedural Complication, Ventricular Fibrillation
Patient was taking Zebeta (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardiac arrest (What is cardiac arrest?), cardiac disorder, cardiomegaly, coronary artery stenosis, depressed level of consciousness, post procedural complication, ventricular fibrillation on Dec 15, 2005 from FINLAND Additional patient health information: Male patient , 73 years of age, weighting 216.1 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Zebeta dosage: 2.5 Mg, Oral. During the same period patient was treated with AMIODARONE HCL (1200 Mg. Single, Intravenous) (View Amiodarone Hcl Review and Amiodarone Hcl Label ), SERENASE DEKANOAT (HALOPERIDOL DECANOATE) (View Serenase Dekanoat (haloperidol Decanoate) Review and Serenase Dekanoat (haloperidol Decanoate) Label ), ANGIOMAX (See Image) (View Angiomax Review and Angiomax Label ), ATIVAN (View Ativan Review and Ativan Label ), NORVASC (View Norvasc Review and Norvasc Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ). Patient was hospitalized.

4842425-6 | Atrial Fibrillation, Cardiac Arrest, Cardiac Disorder, Cardiomegaly, Coronary Artery Stenosis, Post Procedural Complication, Scar, Ventricular Fibrillation
Adverse event was reported on Nov 14, 2005 by a Male patient taking Zebeta (View Usage) (Dosage: 2.5 Mg, Oral) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: FINLAND , 73 years of age, weighting 216.1 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac arrest (What is cardiac arrest?), cardiac disorder, cardiomegaly, coronary artery stenosis, post procedural complication, scar (What is scar?), ventricular fibrillation. During the same period patient was treated with AMIODARONE HYDROCHLORIDE (1200 Mg, Single, Intravenous) (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), BIVALIRUDIN (ANGIOMAX (BIVLIRUBIN) (See Image) (View Bivalirudin (angiomax (bivlirubin) Review and Bivalirudin (angiomax (bivlirubin) Label ). Patient was hospitalized.

4837279-8 | Blood Pressure Systolic Increased, Cerebral Haemorrhage, Ecchymosis, Heart Rate Increased, Hypothermia, Oxygen Saturation Decreased, Pulmonary Congestion
on Nov 07, 2005 Female patient from FRANCE , 86 years of age, weighting 110.2 lb, was treated with Zebeta (View Usage). After Zebeta was administered, patient had the following side effects: blood pressure systolic increased, cerebral haemorrhage, ecchymosis, heart rate increased, hypothermia (What is hypothermia?), oxygen saturation decreased, pulmonary congestion. Zebeta dosage: 1.25 Mg, Bid, Oral. During the same period patient was treated with COVERSYL (PERINDOPRIL) (2 Mg, Bid, Oral) (View Coversyl (perindopril) Review and Coversyl (perindopril) Label ), PREVISCAN (FLUINDIONE) (5 Mg, Qd, Oral) (View Previscan (fluindione) Review and Previscan (fluindione) Label ), FUROSEMIDE (Qd, Oral) (View Furosemide Review and Furosemide Label ), DIGOXIN (0.25 Mg, Qd, Oral) (View Digoxin Review and Digoxin Label ).

4757619-8 | Bundle Branch Block Right, Chronic Obstructive Pulmonary Disease, Cor Pulmonale, Diarrhoea, Dizziness, Lower Respiratory Tract Infection, Malaise
on Aug 16, 2005 Female patient from GERMANY , 65 years of age, was treated with Zebeta (View Usage). Patient experienced the following unwanted or unexpected effects: bundle branch block right, chronic obstructive pulmonary disease, cor pulmonale, diarrhoea, dizziness (What is dizziness?), lower respiratory tract infection, malaise. Zebeta dosage: . During the same period patient was treated with BUMETANIDE (View Bumetanide Review and Bumetanide Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), AMIODARONE (AMIODARONE) TABLET (View Amiodarone (amiodarone) Tablet Review and Amiodarone (amiodarone) Tablet Label ), ACETYLSALICYLIC ACID (ACETYLSALICYLIC ACID) TABLET (View Acetylsalicylic Acid (acetylsalicylic Acid) Tablet Review and Acetylsalicylic Acid (acetylsalicylic Acid) Tablet Label ), BECLOMETHASONE AQUEOUS (BECLOMETASONE DIPROPIONATE) (View Beclomethasone Aqueous (beclometasone Dipropionate) Review and Beclomethasone Aqueous (beclometasone Dipropionate) Label ), METFORMIN (View Metformin Review and Metformin Label ).

4636814-2 | Atrioventricular Block Complete, Bradycardia, Bundle Branch Block Left, Electrocardiogram Qrs Complex Prolonged, Malaise, Pancreatitis Acute, Torsade De Pointes, Ventricular Extrasystoles
Patient was taking Zebeta (View Usage). Patient had the following side effects: atrioventricular block complete, bradycardia, bundle branch block left, electrocardiogram qrs complex prolonged, malaise, pancreatitis acute, torsade de pointes, ventricular extrasystoles on Apr 06, 2005 from Additional patient health information: Female patient , 81 years of age, . Zebeta dosage: 1.25 Mg, Qd, Oral. During the same period patient was treated with MONNO TILDIEM(DILTIAZEM HYDROCHLORIDE) (300.00 Mg, Qd, Oral) (View Monno-tildiem(diltiazem Hydrochloride) Review and Monno-tildiem(diltiazem Hydrochloride) Label ), ALDACTAZIDE (View Aldactazide Review and Aldactazide Label ), COVERSYL (PERINDOPRIL) (View Coversyl (perindopril) Review and Coversyl (perindopril) Label ), PLAVIX (View Plavix Review and Plavix Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.